
AstraZeneca faces fresh China import tax fine of up to $8 million
Audio By Carbonatix By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast cancer drug Enhertu, the drugmaker said on Tuesday, as it works to …